Type
Internal restructuring
Country
Poland
Region
Location of affected unit(s)
NA
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

250 jobs
Number of planned job losses
Job loss
Announcement Date
2 October 2020
Employment effect (start)
2 October 2020
Foreseen end date
31 December 2020

Description

Polish pharmaceutical company Polpharma announced that it will cut about 250 jobs throughout a collective dismissal programme at its units across Poland by the end of 2020. The restructuring programme will affect mainly office staff, and the conditions of the programme will be negotiated with the employees’ representatives. The job cuts are related to the COVID-19 pandemic.

Polpharma was founded as a state-owned company in 1935; it was privatized in 2000. Currently, Polpharma is a leading company on the Polish pharmaceutical market and one of the major drug manufacturers in the region of CEE, Central Asia and the Caucasus. The company employs 4,500 people at five production facilities across Poland. 


Sources

Citation

Eurofound (2020), Polpharma, Internal restructuring in Poland, factsheet number 102142, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/102142.